Mark Pruzanski

Mark Pruzanski

Directeur/Membre du Conseil chez EQUILLIUM, INC.

Fortune : 43 076 $ au 30/04/2024

56 ans
Health Technology
Consumer Services
Commercial Services

Provenance du réseau au premier degré de Mark Pruzanski

EntitéType d'entitéIndustrie
220
Non-Profit Organization Miscellaneous Commercial Services 220
Public Company Pharmaceuticals: Major 57
Public Company Biotechnology 18
11
Holding Company Miscellaneous Commercial Services 11
9
Holding Company Pharmaceuticals: Major 9
7
Subsidiary Biotechnology 7
Foundation for the Defense of Democracies
7
Private Company 7
3
Subsidiary Miscellaneous Commercial Services 3

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Mark Pruzanski via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
College/University

Jonathan Leff

Bruce W. Ferguson

N. Coles

Carlos Riva

Jeffrey D. Marrazzo

Bradley A. Shurdut

Julie Sunderland

Lloyd Klickstein

Undergraduate Degree

Masters Business Admin

Graduate Degree

Masters Business Admin

Graduate Degree

Graduate Degree

Undergraduate Degree

Doctorate Degree

ELI LILLY AND COMPANY Pharmaceuticals: Major

Steven Paul

Lorenzo M. Tallarigo

Edward O. Lanphier

Edmundo Manuel Muniz

James Sapirstein

Martin Babler

Chief Tech/Sci/R&D Officer

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

Chief Operating Officer

Corporate Officer/Principal

Pharmaceuticals: Major

Richard Pops

Daniel Bradbury

Renee Connolly

Herve Hoppenot

Pamela M. Williamson

Sebastian Guth

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Corporate Officer/Principal

Director/Board Member

The Wharton School of the University of Pennsylvania College/University

Barbara Duncan

Barbara Troupin

Jonathan Lloyd Jones

Jeffrey D. Marrazzo

Julie Sunderland

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Medical Specialties

Jonathan Lloyd Jones

David Meeker

William Sibold

Pamela M. Williamson

Corporate Officer/Principal

Chief Executive Officer

President

Public Communications Contact

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Helen Torley

Jeremy Levin

N. Coles

James Sapirstein

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Rutgers State University of New Jersey College/University

John Orwin

James Sapirstein

Robert Repella

Sandipkumar S. Kapadia

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

Miscellaneous Commercial Services

Carl Feldbaum

Jeremy Levin

Edward O. Lanphier

Ted Love

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

SEAGEN INC. Pharmaceuticals: Major

Ted Love

Clay Siegall

John Orwin

Director/Board Member

Chief Executive Officer

Director/Board Member

GILEAD SCIENCES, INC. Biotechnology

Ted Love

James Sapirstein

Lisa Bright

Director/Board Member

Sales & Marketing

Corporate Officer/Principal

IMMUNOMEDICS, INC. Biotechnology

Barbara Duncan

David Stack

Jared M. Freedberg

Director/Board Member

Sales & Marketing

General Counsel

BIOGEN INC. Pharmaceuticals: Major

Steven Holtzman

John Maraganore

William Sibold

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Pyott

Steven Paul

John Maraganore

Director/Board Member

Director/Board Member

Chief Executive Officer

NOVARTIS AG Pharmaceuticals: Major

David Pyott

Flemming Ørnskov

Ludwig Hantson

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

MACROGENICS, INC. Pharmaceuticals: Major

Paul Sekhri

John Maraganore

Scott Koenig

Director/Board Member

Chairman

Founder

MERCK & CO., INC. Pharmaceuticals: Major

N. Coles

Julie Gerberding

Donald P. Beeman

Corporate Officer/Principal

Public Communications Contact

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Fabrizio Bonanni

Helen Torley

William Sibold

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Mitchell S. Bloom

Renee Connolly

Pamela M. Williamson

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Helen Torley

Ted Love

N. Coles

Chief Operating Officer

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Biotechnology

Ted Love

John Orwin

Martin Babler

General Counsel

Corporate Officer/Principal

Sales & Marketing

RELYPSA INC Pharmaceuticals: Major

Helen Torley

Jonathan Silverstein

John Orwin

Director/Board Member

Director/Board Member

Chief Executive Officer

Yale University College/University

Arthur Sands

Christopher G. Standlee

William Sibold

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

GSK PLC Pharmaceuticals: Major

Robert Ruffolo

Lisa Bright

Eric Dube

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Ludwig Hantson

Herve Hoppenot

Sandipkumar S. Kapadia

Corporate Officer/Principal

President

Corporate Officer/Principal

General Government

Steven Paul

Scott Koenig

Robert J. Beall

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

BIOCON LIMITED Pharmaceuticals: Major

Bala S. Manian

Jeremy Levin

Daniel Bradbury

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Steven Paul

Julie Gerberding

Chairman

Chief Executive Officer

Advertising/Marketing Services

Hugh Grant

James Collins

Director/Board Member

Director/Board Member

SPARK THERAPEUTICS, INC. Biotechnology

Vin Milano Milano

Jeffrey D. Marrazzo

Director/Board Member

Founder

University of California, Berkeley College/University

Matthew Pfeffer

Julie Gerberding

Undergraduate Degree

Graduate Degree

TRANSLATE BIO, INC. Biotechnology

Jean-Francois Formela

Mitchell S. Bloom

Founder

Corporate Officer/Principal

Miscellaneous Commercial Services

Vin Milano Milano

Robert Repella

Chairman

Director/Board Member

VANDA PHARMACEUTICALS INC. Pharmaceuticals: Major

Vin Milano Milano

Robert Repella

Director/Board Member

Corporate Officer/Principal

Investment Managers

Paul Sekhri

David Stack

Private Equity Investor

Private Equity Investor

Biotechnology

Steven Paul

John Maraganore

Founder

Director/Board Member

Biotechnology

Mark B. Skaletsky

John Maraganore

President

Corporate Officer/Principal

HALOZYME THERAPEUTICS, INC. Biotechnology

Barbara Duncan

Helen Torley

Director/Board Member

Chief Executive Officer

Miscellaneous Commercial Services

Steven Paul

Julie Gerberding

Corporate Officer/Principal

Corporate Officer/Principal

Medical/Nursing Services

Steven Paul

Edward O. Lanphier

Director/Board Member

Chairman

AFFYMAX, INC. Biotechnology

Ted Love

John Orwin

Director/Board Member

Chief Executive Officer

INNOVIVA, INC. Pharmaceuticals: Major

Barbara Duncan

Ted Love

Director/Board Member

Corporate Officer/Principal

OVID THERAPEUTICS INC. Pharmaceuticals: Major

Barbara Duncan

Jeremy Levin

Director/Board Member

Chief Executive Officer

Princeton University College/University

Carl Feldbaum

Ronald Cohen

Undergraduate Degree

Undergraduate Degree

Massachusetts Institute of Technology College/University

Carlos Riva

Jeffrey Peterson

Undergraduate Degree

Graduate Degree

University of Georgia College/University

Pearce Gilbert

Cartier Esham

Graduate Degree

Doctorate Degree

Statistiques

Internationale

Etats-Unis 47
Suisse 2
Royaume-Uni 2
Inde 2
Belgique 2

Sectorielle

Health Technology 33
Consumer Services 8
Commercial Services 8
Finance 3
Government 2

Opérationnelle

Director/Board Member 854
Corporate Officer/Principal 268
Independent Dir/Board Member 216
Chairman 194
Chief Executive Officer 142
  1. Bourse
  2. Insiders
  3. Mark Pruzanski
  4. Connexions Sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT